COMPARATIVE MORPHOMETRIC STUDY OF DIFFERENT AREAS OF ATRIA IN PAROXYSMAL AND CHRONIC ATRIAL FIBRILLATION
Abstract
С целью сравнительного морфометрического анализа патологических изменений в различных точках предсердий при пароксизмальной и постоянной фибрилляции предсердий исследовано 21 сердце умерших больных, страдавших ишемической болезнью сердца с острым инфарктом миокарда или постинфарктным кардиосклерозом в возрасте от 38 до 82 лет, средний возраст 61±11 лет, 9 женщин и 12 мужчин.
About the Authors
L. B. Mitrofanova
ФГУ «ФЦ сердца, крови и эндокринологии им. В.А. Алмазова», Санкт-Петербург
Russian Federation
Russian Federation
D. S. Lebedev
ФГУ «ФЦ сердца, крови и эндокринологии им. В.А. Алмазова», Санкт-Петербург
Russian Federation
Russian Federation
I. V. Antonova
ФГУ «ФЦ сердца, крови и эндокринологии им. В.А. Алмазова», Санкт-Петербург
Russian Federation
Russian Federation
P. G. Platonov
Лундский Университет, Швеция
Russian Federation
Russian Federation
References
1. Митрофанова Л.Б., Кудайбергенова А.Г., Антонова И.В. Фибрилляция предсердий, амилоидоз, миокардит и вирусная инфекция // Артериальная гипертензия. -2009. - Т.15, №2. - C. 203-209.
2. Смольянников А.В., Наддачина Т.А. Патологическая анатомия коронарной недостаточности. - Москва: Медгиз, 1963. - 245 c.
3. Boldt A., Wetzel U., Lauschke J. et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease // Heart. - 2004. - Vol.90. - P. 400-405.
4. Burns T.R, Klima M., Teasdale T.A, Kasper K. Morphometry of the aging heart // Mod Pathol. - 1990. - Vol.3. - P. 336-42.
5. Dorian P. The future of atrial fibrillation therapy // J. Cardiovasc. Electrophysiol. - 2006. - Vol.17. - P. 11-16.
6. Everett T.H., Olgin J.E. Atrial fibrosis and the Mechanisms of atrial fibrillation // Heart Rhythm. - 2007. - Vol.4 (3 suppl). - P. 24-27.
7. Frustaci A., Chimenti C., Bellocci P. et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation // Circulation. - 1997. - Vol. 96. - P. 1180-1184.
8. Karatolios K., Pankuweit S., Kisselbach Ch., Maisch B. Inflammatory Cardiomyopathy // Hellenic. J. Cardiol. - 2006. - Vol.47. - P. 54-65.
9. Kostapanos M.S., Liberopoulos E.N., Goudevenos J.A. et al. Do statins have an antiarrhythmic activity? // Cardiovasc. Res. - 2007. - Vol.75. - P.10-20.
10. Kumagai K., Nakashima H., Saku K. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model // Cardiovascular. Res. - 2004. - Vol.62. - P. 105111.
11. Libby P., Ridker P., Maseri A. Inflammation and atherosclerosis // Circulation. - 2002. - Vol.105. - P. 11351143.
12. Lin Y.Z., Xu C.X., Deng Y.L. et al. Effects of tetramethylpyrazine on fibrosis of atrial tissue and atrial fibrillation in a canine model of congestive heart failure induced by ventricular tachypacing // Zhong Xi Yi Jie He Xue Bao. - 2006. - Vol.4. - P. 35-38.
13. Lopez B, Querejeta R., Varo N. et al. Usefulness of serum carboxy-terminal propertied of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients // Circulation. - 2001. - Vol.104. - P.286-291.
14. Morrow D., Rifai N., Antman E. et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI IIA substudy. Thrombolysis in myocardial infarction // J. Am. Coll. Cardiol. - 1998. - Vol.31. - P.1360-1465.
15. Nakamura Y., Nakamura K, Fukushima-Kusano K. et al. Tissue factor expression in atrial endotelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis // Thromb. Res. - 2003. -Vol.111. - P.137-142.
16. Patel A.A., White C.M., Shah S.A. et al. The relationship between statin use and atrial fibrillation // Curr. Med. Res. Opin. - 2007. - Vol.23. - P.1177-1185.
17. Pellman J., Lyon R.C., Sheikh F. Extracellular matrix remodeling in atrial fibrosis: mechanisms and implications in atrial fibrillation // J. Mol. Cell. Cardiol. -2010. - Vol.48. - P.461-467.
18. Saba S., Janczewski A.M., Baker L.C. et al. Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-{alfa} // Am. J Physiol. Heart Circ. Physiol. - 2005. - Vol.289. - P. 14561467.
19. Sanchez-Quinones J., Marin F., Roldan V., Lip G.Y.H. The impact of statin use on atrial fibrillation // Oxford J. Medicine. - 2008. - Vol.101. - P.845-861.
20. Tamargo J., Caballero R., Gomez R. et al. Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy. // Pharmacol. Ther. - 2007. - Vol.114. - P.107-126.
21. Tanaka K., Zlochiver S., Vikstrom K.L. et al. The spatial distribution of fibrosis governs fibrillation wave dynamics in posterior left atrium during heart failure // Circ. Res. - 2007. - Vol.101. - P. 839-847.
Review
For citations:
Mitrofanova L.B., Lebedev D.S., Antonova I.V., Platonov P.G. COMPARATIVE MORPHOMETRIC STUDY OF DIFFERENT AREAS OF ATRIA IN PAROXYSMAL AND CHRONIC ATRIAL FIBRILLATION. Journal of Arrhythmology. 2010;62(62):32-36. (In Russ.)
Views:
115
Email this article 